These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 32896820)

  • 1. Pharmacotherapy in multiple sclerosis-induced cognitive impairment: A systematic review and meta-analysis.
    Motavalli A; Majdi A; Hosseini L; Talebi M; Mahmoudi J; Hosseini SH; Sadigh-Eteghad S
    Mult Scler Relat Disord; 2020 Nov; 46():102478. PubMed ID: 32896820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trail Making Test Could Predict Impairment in Cognitive Domains in Patients with Multiple Sclerosis: A Study of Diagnostic Accuracy.
    Kabiri S; Jameie M; Balali P; Adib Moradi S; Sanjari Moghaddam H; Aghamollaii V; Harirchian MH
    Arch Clin Neuropsychol; 2023 Jan; 38(1):37-48. PubMed ID: 35901460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of the French version of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS).
    Maubeuge N; Deloire MSA; Brochet B; Ehrlé N; Charré-Morin J; Saubusse A; Ruet A;
    Mult Scler Relat Disord; 2021 Feb; 48():102692. PubMed ID: 33352358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum lipids and cognitive outcomes in multiple sclerosis; a systematic review and meta-analysis.
    Sanaie S; Koohi N; Mosaddeghi-Heris R; Rezai S; Movagharnia E; Karimi H; Moghaddamziabari S; Hamzehzadeh S; Gholipour-Khalili E; Talebi M; Naseri A
    Mult Scler Relat Disord; 2024 May; 85():105530. PubMed ID: 38522226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between cognitive changes and neuroradiological changes over time in multiple sclerosis: a systematic review and meta-analysis.
    Simani L; Molaeipour L; Kian S; Leavitt VM
    J Neurol; 2024 Aug; 271(8):5498-5518. PubMed ID: 38890188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A one-year follow-up study of the Symbol Digit Modalities Test (SDMT) and the Paced Auditory Serial Addition Test (PASAT) in relapsing-remitting multiple sclerosis: an appraisal of comparative longitudinal sensitivity.
    López-Góngora M; Querol L; Escartín A
    BMC Neurol; 2015 Mar; 15():40. PubMed ID: 25886168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Cambridge Neuropsychological Test Automated Battery (CANTAB) Versus the Minimal Assessment of Cognitive Function in Multiple Sclerosis (MACFIMS) for the Assessment of Cognitive Function in Patients with Multiple Sclerosis.
    Talebi M; Majdi A; Kamari F; Sadigh-Eteghad S
    Mult Scler Relat Disord; 2020 Aug; 43():102172. PubMed ID: 32442887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of L-amphetamine sulfate on cognition in MS patients: results of a randomized controlled trial.
    Morrow SA; Kaushik T; Zarevics P; Erlanger D; Bear MF; Munschauer FE; Benedict RH
    J Neurol; 2009 Jul; 256(7):1095-102. PubMed ID: 19263186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sleep and cognitive outcomes in multiple sclerosis; a systematic review.
    Golabi B; Razmaray H; Seyedi-Sahebari S; Bandehagh H; Hakimzadeh Z; Khosroshahi A; Moghaddamziabari S; Aghaei N; Sanaie S; Talebi M; Naseri A
    BMC Psychiatry; 2024 Sep; 24(1):638. PubMed ID: 39342299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing the criterion validity of four highly abbreviated measures from the Minimal Assessment of Cognitive Function in Multiple Sclerosis (MACFIMS).
    Gromisch ES; Zemon V; Holtzer R; Chiaravalloti ND; DeLuca J; Beier M; Farrell E; Snyder S; Schairer LC; Glukhovsky L; Botvinick J; Sloan J; Picone MA; Kim S; Foley FW
    Clin Neuropsychol; 2016 Oct; 30(7):1032-49. PubMed ID: 27279357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brief international cognitive assessment for multiple sclerosis (BICAMS): A danish validation study of sensitivity in early stages of MS.
    Marstrand L; Østerberg O; Walsted T; Skov AC; Schreiber KI; Sellebjerg F
    Mult Scler Relat Disord; 2020 Jan; 37():101458. PubMed ID: 31683230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of cognitive rehabilitation in comparison with routine rehabilitation methods in patients with multiple sclerosis: A systematic review and meta-analysis.
    Rayegani SM; Heidari S; Seyed-Nezhad M; Kiyani N; Moradi-Joo M
    Mult Scler J Exp Transl Clin; 2024; 10(3):20552173241272561. PubMed ID: 39290831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Instruments measuring change in cognitive function in multiple sclerosis: A systematic review.
    Ezegbe C; Zarghami A; van der Mei I; Alty J; Honan C; Taylor B
    Brain Behav; 2023 Jun; 13(6):e3009. PubMed ID: 37062948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A preliminary validation of the brief international cognitive assessment for multiple sclerosis (BICAMS) tool in an Irish population with multiple sclerosis (MS).
    O'Connell K; Langdon D; Tubridy N; Hutchinson M; McGuigan C
    Mult Scler Relat Disord; 2015 Nov; 4(6):521-5. PubMed ID: 26590658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T1 and T2 weighted lesions and cognition in multiple Sclerosis: A systematic review and meta-analysis.
    Nabizadeh F; Pirahesh K; Azami M; Moradkhani A; Sardaripour A; Ramezannezhad E
    J Clin Neurosci; 2024 Jan; 119():1-7. PubMed ID: 37952373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of depression and anxiety on cognition in people with multiple sclerosis: a cross-sectional analysis.
    Freedman DE; Oh J; Kiss A; Puopolo J; Wishart M; Meza C; Feinstein A
    J Neurol; 2024 Aug; 271(8):4885-4896. PubMed ID: 38730098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Olfactory function and cognition in relapsing-remitting and secondary-progressive multiple sclerosis.
    Carotenuto A; Costabile T; Moccia M; Falco F; Scala MR; Russo CV; Saccà F; De Rosa A; Lanzillo R; Brescia Morra V
    Mult Scler Relat Disord; 2019 Jan; 27():1-6. PubMed ID: 30273697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing Cognitive Function in Multiple Sclerosis With Digital Tools: Observational Study.
    Hsu WY; Rowles W; Anguera JA; Anderson A; Younger JW; Friedman S; Gazzaley A; Bove R
    J Med Internet Res; 2021 Dec; 23(12):e25748. PubMed ID: 34967751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening for cognitive impairment in multiple sclerosis using the Symbol digit Modalities Test.
    Parmenter BA; Weinstock-Guttman B; Garg N; Munschauer F; Benedict RH
    Mult Scler; 2007 Jan; 13(1):52-7. PubMed ID: 17294611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Symbol Digit Modalities Test as sentinel test for cognitive impairment in multiple sclerosis.
    Van Schependom J; D'hooghe MB; Cleynhens K; D'hooge M; Haelewyck MC; De Keyser J; Nagels G
    Eur J Neurol; 2014 Sep; 21(9):1219-25, e71-2. PubMed ID: 24850580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.